Compartmental Model for 223Ra-Dichloride in Patients With Metastatic Bone Disease From Castration-Resistant Prostate Cancer
Open Access
- 1 November 2019
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 105 (4) , 884-892
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate CancerNew England Journal of Medicine, 2013
- Targeted radio-nuclide therapy of skeletal metastasesCancer Treatment Reviews, 2013
- Dosimetry of 223Ra-chloride: dose to normal organs and tissuesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- Quantitative imaging of 223Ra-chloride (Alpharadin) for targeted alpha-emitting radionuclide therapy of bone metastasesNuclear Medicine Communications, 2012
- A bone marrow toxicity model for223Ra alpha-emitter radiopharmaceutical therapyPhysics in Medicine & Biology, 2012
- Development of Compartmental Models in Stable-Isotope ExperimentsArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- SAAM II: Simulation, analysis, and modeling software for tracer and pharmacokinetic studiesMetabolism, 1998
- Basic anatomical and physiological data: The skeletonAnnals of the ICRP, 1995
- High-LET radiations induce a large proportion of non-rejoining DNA breaksNature, 1977
- A new look at the statistical model identificationIEEE Transactions on Automatic Control, 1974